Clinical Trial Update: Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 trial update on using amiodarone for atrial fibrillation in patients with severe sepsis or septic shock; the study is terminated with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Sepsis
• Septic Shock

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: New Onset Atrial Fibrillation, Severe Sepsis | Phase 4 | Status: TERMINATED | Results posted: 2019-04-02